Aarkstore - Post-Operative Pain - Pipeline Review, H2 2014

1
Post-Operative Pain - Pipeline Review, H2 2014
Pharmaceutical and Healthcare Market Research
Report
2
Summary

• Post-Operative Pain - Pipeline Review, H2 2014,
  provides an overview of the Post-Operative Pains
  therapeutic pipeline.
• This report provides comprehensive information
  on the therapeutic development for Post-Operative
  Pain, complete with comparative analysis at
  various stages, therapeutics assessment by drug
  target, mechanism of action (MoA), route of
  administration (RoA) and molecule type, along
  with latest updates, and featured news and press
  releases. It also reviews key players involved in
  the therapeutic development for Post-Operative
  Pain and special features on late-stage and
  discontinued projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.
  Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. 

3
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Post-Operative Pain-
  The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities - The report reviews key players
  involved in the therapeutics development for
  Post-Operative Pain and enlists all their major
  and minor projects- The report summarizes all
  the dormant and discontinued pipeline projects -
  A review of the Post-Operative Pain products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects- Coverage of the Post-Operative Pain
  pipeline on the basis of target, MoA, route of
  administration and molecule type- Latest news
  and deals relating related to pipeline products

4
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies- Identify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantage- Develop strategic
  initiatives by understanding the focus areas of
  leading companies- Identify and understand
  important and diverse types of therapeutics under
  development for Post-Operative Pain- Plan
  mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline- Devise corrective measures for
  pipeline projects by understanding Post-Operative
  Pain pipeline depth and focus of Indication
  therapeutics- Develop and design in-licensing
  and out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and Scope- Modify the therapeutic portfolio by
  identifying discontinued projects and
  understanding the factors that drove them from
  pipeline

5
Table of Content

• Introduction 10Global Markets Direct Report
  Coverage 10Post-Operative Pain Overview
  11Therapeutics Development 12Pipeline Products
  for Post-Operative Pain - Overview 12Pipeline
  Products for Post-Operative Pain - Comparative
  Analysis 13Post-Operative Pain - Therapeutics
  under Development by Companies 14Post-Operative
  Pain - Pipeline Products Glance 17Late Stage
  Products 17Clinical Stage Products 18Early
  Stage Products 19Post-Operative Pain - Products
  under Development by Companies 20Post-Operative
  Pain - Companies Involved in Therapeutics
  Development 23A. Menarini Industrie
  Farmaceutiche Riunite Srl 23AcelRx
  Pharmaceuticals, Inc. 24

6
List of Tables

• Number of Products under Development for
  Post-Operative Pain, H2 2014 12Number of
  Products under Development for Post-Operative
  Pain - Comparative Analysis, H2 2014 13Number of
  Products under Development by Companies, H2 2014
  15Number of Products under Development by
  Companies, H2 2014 (Contd..1) 16Comparative
  Analysis by Late Stage Development, H2 2014
  17Comparative Analysis by Clinical Stage
  Development, H2 2014 18Comparative Analysis by
  Early Stage Development, H2 2014 19Products
  under Development by Companies, H2 2014
  20Products under Development by Companies, H2
  2014 (Contd..1) 21Products under Development by
  Companies, H2 2014 (Contd..2) 22Post-Operative
  Pain - Pipeline by A. Menarini Industrie
  Farmaceutiche Riunite Srl, H2 2014
  23Post-Operative Pain - Pipeline by AcelRx
  Pharmaceuticals, Inc., H2 2014 24Post-Operative
  Pain - Pipeline by Adynxx, Inc., H2 2014
  25Post-Operative Pain - Pipeline by AngioChem
  Inc., H2 2014 26Post-Operative Pain - Pipeline
  by Aoxing Pharmaceutical Company, Inc, H2 2014
  27Post-Operative Pain - Pipeline by Boehringer
  Ingelheim GmbH, H2 2014 28

7
List of Figures

• Number of Products under Development for
  Post-Operative Pain, H2 2014 12Number of
  Products under Development for Post-Operative
  Pain - Comparative Analysis, H2 2014 13Number of
  Products under Development by Companies, H2 2014
  14Comparative Analysis by Late Stage
  Development, H2 2014 17Comparative Analysis by
  Clinical Stage Development, H2 2014
  18Comparative Analysis by Early Stage Products,
  H2 2014 19Assessment by Monotherapy Products, H2
  2014 55Assessment by Combination Products, H2
  2014 56Number of Products by Top 10 Targets, H2
  2014 57Number of Products by Stage and Top 10
  Targets, H2 2014 57Number of Products by Top 10
  Mechanism of Actions, H2 2014 59Number of
  Products by Stage and Top 10 Mechanism of
  Actions, H2 2014 59Number of Products by Top 10
  Routes of Administration, H2 2014 61Number of
  Products by Stage and Top 10 Routes of
  Administration, H2 2014 62Number of Products by
  Top 10 Molecule Types, H2 2014 63

8
Related Reports

• Fabry Disease-Pipeline Insights, 2015
• Ocular Hypertension-Pipeline Insights, 2015
• Fallopian Tube Cancer-Pipeline Insights, 2015
• Ocular Inflammation-Pipeline Insights, 2015
• Familial Adenomatous Polyposis Coli-Pipeline
  Insights, 2015
• Ocular Pain-Pipeline Insights, 2015
• Oligodendroglioma-Pipeline Insights, 2015
• Familial Chylomicronemia (Type I
  Hyperlipoproteinemia)-Pipeline Insights, 2015

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953